< Back to previous page
Researcher
Johan Neyts
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 30 Sep 2002 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 79
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Towards strategies for the treatment and prevention of henipavirus infections.From21 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- HTS to discover direct-acting small molecule inhibitors of henipavirusesFrom16 Nov 2022 → TodayFunding: Foreign private sponsor - undefined
- Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolutionFrom1 Jan 2022 → TodayFunding: FWO EOS
- VirusBank platform (state-of-the-art research platform for increased preparedness against viral epidemics and pandemics)From1 Jan 2022 → TodayFunding: Ministery of Economical Affairs
- NextEboVax: Next generation vaccines for outbreak prepardnessFrom15 Sep 2021 → TodayFunding: FWO Strategic Basic Research Grant
- GUT VIrus BRain Axis Technology In OrgaNoid ScienceFrom1 Apr 2021 → TodayFunding: H2020 - Leadership in enabling and industrial technologies (LEIT)
- Towards a thermostable dual yellow fever/Lassa fever virus vaccine and therapeutic strategies against the Lassa and related mammarenaviruses.From1 Nov 2020 → 31 Oct 2022Funding: FWO junior postdoctoral fellowship
- Assessing the risk of SARS-CoV-2 infection for pregnancy and as possible cause of birth defectsFrom1 Nov 2020 → 31 Oct 2021Funding: FWO thematic call for applied research
Publications
1 - 10 of 604
- Toward antivirals against hepatitis E: In the steps of hepatitis C.(2023)
Authors: Johan Neyts
Pages: 1695 - 1697 - Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.(2023)
Authors: Steven De Jonghe, Kim Donckers, Dirk Jochmans, Johan Neyts
Pages: eabo7201 - Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411(2023)
Authors: Dirk Jochmans, Johan Neyts
- Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters(2023)
Authors: Rana Abdelnabi, Winnie Kerstens, Lotte Coelmont, Birgit Weynand, Johan Neyts, Kai Dallmeier
- Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects(2023)
Authors: Dirk Jochmans, Johan Neyts, Steven De Jonghe, Pieter Leyssen
- Comprehensive study of alkaloids from Scadoxus multiflorus by HPLC-PDA-SPE-NMR and evaluation of their anti-SARS-CoV-2 activity(2023)
Authors: Steven De Jonghe, Johan Neyts
Pages: 156 - 162 - Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents(2023)
Authors: Johan Neyts, Dirk Jochmans, Graciela Andrei, Robert Snoeck
Pages: 2147 - 2159 - Moral-oids: An Ethical Exploration of Organoid Models in Biomedical Research(2023)
Authors: Andrew Barnhart, Kris Dierickx, Johan Neyts
- Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies(2023)
Authors: Tania Roskams, Lotte Coelmont, Johan Neyts, Suzanne Kaptein
- YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge(2023)
Authors: Viktor Lemmens, Lara Kelchtermans, Ji Ma, Hendrik Jan Thibaut, Johan Neyts, Kai Dallmeier
Patents
1 - 10 of 10
- Chimeric filovirus vaccines (Inventor)
- Chimeric zika-japanese encephalitis virus (Inventor)
- Lassavirus vaccines (Inventor)
- Corona virus binders (Inventor)
- Chimeric yellow fever zika virus strain (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Viral replication inhibitors (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Corona virus binders (Inventor)